Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by Packerfan666on Jul 30, 2018 5:25pm

94 Views

Post# 28387787

RE:Observations

Buddy give it a rest. If you have sold get off of here. I gave you some substance. I haven’t pumped anything. I have actually in fact made positive comments while saying there is lots of risk. I just recently started posting as I listened to the garbage you post that has no substance. If you sold get off the board. Why are you here ?? Take your loss.., go cry somewhere else. You sound like a pathetic baby. Either I will be right or you will. Only time will tell. I haven’t asked anyone to invest nor have I made any predictions. I have stated facts. Go back through my posts and show me where I pumped???? Idiot

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading